GlassScriptPhysician profile
Dean Amundsen
NPI 1003021205
$4,749.33
in general payments reported to CMS, 2019-2025
13 companies · $29.25 in 2025
The $29.25 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $18.33 · 2021: $29.40 · 2022: $41.37 · 2023: $4,232 · 2024: $135 · 2025: $29.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,465 · Travel and Lodging: $1,252 · Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,465.00 |
| Travel and Lodging | $1,252.00 |
| Food and Beverage | $679.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $4,007.45 | 2019-2023 | Acuvue |
| Novartis Pharmaceuticals Corporation | $155.06 | 2019-2021 | |
| Coopervision INC. | $141.97 | 2022-2024 | Paragon Crt, Onefit Contact Lens |
| Alcon Vision LLC | $126.01 | 2019-2024 | Total30 |
| Sun Pharmaceutical Industries INC. | $122.93 | 2019-2023 | Cequa |
| Lkc Technologies, INC. | $45.92 | 2024 | |
| Bausch & Lomb Americas INC. | $36.98 | 2023-2024 | Infuse, Miebo |
| Abbvie INC. | $29.25 | 2025 | |
| Allergan, INC. | $25.59 | 2021-2022 | |
| Oyster Point Pharma, INC. | $19.89 | 2023 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $12.91 | 2019 | |
| Optos, INC. | $12.79 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Amundsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.